Back to 
STATE STREET CORP
STATE STREET CORP
CLDXShowing 8 of 11 quarters
Position history for STATE STREET CORP's holdings in Celldex Therapeutics, Inc.
STATE STREET CORP holds 3.9M shares of CLDX (Celldex Therapeutics, Inc.), worth $145.1M as of 2026-Q2. The position was increased (+39.1% shares). CLDX represents 0.0% of STATE STREET CORP's portfolio.
Current Value
$145.1M
Current Shares
3.9M
Total Value Change
+$60.7M
Total Shares Change
+1.4M
Quarter-by-Quarter History
Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP